Independent · Mechanism-First · Evidence-Graded
Health evidence reviews, original sequence research, mechanisms and documentary investigations: the clearance-and-tolerance framework, pathway mechanics, and the natural compounds that act as levers within it.
Start here · All articles · Methodology · About the publication
Investigations into natural compounds, cellular health mechanisms, and evidence-based wellness protocols.
The most developed work on this site. A unified framework for chronic spike-related illness as systemic clearance and tolerance failure under persistent antigenic drive: pathway mechanics (mTOR, glymphatic, SIRT1), five mechanistic subtypes, a tiered biomarker matrix, and intervention protocols. Evidence-graded, primary-source, falsifiable.
For over a century, evidence of spirochetal brain infection lagged decades behind acceptance. Spike Protein pathology is now tracing the same endothelial route. The continuity, stated at the strength the evidence carries.
A century of autopsy reports describing Borrelia in MS brains, why standard testing misses a subset of cases, the MS-causation hypothesis stated as a hypothesis, and food-level steps to lower inflammatory load now.
Peer-reviewed evidence for spike-induced amyloid fibrin microclots in Long COVID, the diagnostic gap created by standard coagulation panels, and the treatment landscape. Investigator reports are separated from peer-reviewed work.
Recent studies, including 2024-2025 work, indicate SARS-CoV-2 and its spike protein can persist for months, with links to immune changes, latent herpesvirus reactivation, and fibrin(ogen) amyloid microclots. These mechanisms may help explain features of Long COVID and some post-vaccination syndromes.
TL;DR# The core finding: mRNA vaccines contain bacterial DNA with active SV40 promoter sequences: contamination confirmed by 8 independent laboratories across four continents, with levels up to 627-fold above regulatory limits and 815-fold variance between batches. ...
The 18.5-day onset-to-death interval comes from a hospital inpatient cohort, not nursing homes. Care-home datasets show different intervals (11 and 22 days in Scotland, 12 in France), which makes the interval a question rather than proof. The measurable is measured; the datasets connecting treatment decisions to deaths were never collected.
When Pfizer switched from clinical trial production to mass manufacturing, they changed everything from DNA templates to purification methods. Internal emails reveal regulators were alarmed by unexpected DNA contaminants with known risks, while patent documents show manufacturers long understood these dangers.
One-page evidence synthesis of established facts, mechanistic inferences, and open questions across three defense layers: systemic genomic defense, cardiac protection, and mast cell stabilization.
Comprehensive visual pathway diagrams from mutagen exposure and spike persistence to genomic instability, with cardiac and mast cell defense layers.
Curated archive of peer-reviewed sources on SDF-1/CXCL12, stem-cell mobilisation, fibrinaloid microclots, and spike-fibrinogen interactions. Companion to the main Amyloid Fibrin Microclots review.
What the gut-skin axis evidence shows for acne, eczema, psoriasis, and rosacea: microbial metabolites, especially butyrate, and how far the human data actually go. Includes a practical protocol that no trial has tested as a sequence.
TUDCA graded claim by claim: the chemical-chaperone mechanism and bile physiology are solid; the strongest human data are the ALS program (phase III trial, positive survival cohort); liver, metabolic, and neuroprotection claims are mostly animal work. Doses and cautions.